Medicus Pharma (MDCX) Cash from Operations (2024 - 2025)

Medicus Pharma (MDCX) reported Cash from Operations of 6609115.0 for Q4 2025, down 107.08% on a YoY basis from 93328794.6 in Q4 2024, and up 2.2% quarter-over-quarter from 6757829.0 in Q3 2025.

Medicus Pharma (MDCX) Cash from Operations (2024 - 2025) Analysis & Trends

Medicus Pharma has reported Cash from Operations for 2 years, with the latest figure at 6609115.0 in Q4 2025.

  • For the quarter ending Q4 2025, Cash from Operations fell 107.08% year-over-year to 6609115.0; the trailing twelve-month figure through Dec 2025 stood at 22776769.0 (down 122.27% YoY), and the FY2025 full-year result was 22776769.0, down 122.27% from the prior year.
  • Cash from Operations for Q4 2025 stood at 6609115.0, up from 6757829.0 in the prior quarter.
  • The five-year high for Cash from Operations was 1176933.0 in Q1 2024, with the low at 6757829.0 in Q3 2025.
Generated on {Timestamp} © BusinessQuant.com
Generated on {Timestamp} Powered by BusinessQuant Logo

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Ops. (Qtr)
1 Gsk 92,316,836.42 Bn 92,316,831.46 Bn 7.76 Bn 1.82 Bn
2 Eli Lilly 983.57 Bn 978.29 Bn 16.22 Bn 5.33 Bn
3 Johnson & Johnson 553.56 Bn 531.50 Bn 15.96 Bn 2.51 Bn
4 AbbVie 383.35 Bn 374.00 Bn 10.78 Bn 3.83 Bn
5 Merck 281.71 Bn 276.06 Bn 12.09 Bn 3.92 Bn
6 Amgen 182.20 Bn 170.16 Bn 5.87 Bn 2.19 Bn
7 Gilead Sciences 153.71 Bn 145.98 Bn 5.52 Bn 2.54 Bn
8 Pfizer 143.75 Bn 130.98 Bn -1.21 Bn 2.62 Bn
9 Bristol Myers Squibb 109.71 Bn 99.25 Bn 8.07 Bn 1.10 Bn
10 Medicus Pharma 7.87 Mn 7.98 Mn - -6.61 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 -6.61 Mn
Dec 31, 2025 -6.61 Mn
Sep 30, 2025 -6.76 Mn
Sep 30, 2025 -6.76 Mn
Jun 30, 2025 -5.47 Mn
Jun 30, 2025 -5.47 Mn
Mar 31, 2025 -3.94 Mn
Mar 31, 2025 -3.94 Mn
Dec 31, 2024 -3.19 Mn
Dec 31, 2024 -3.19 Mn
Sep 30, 2024 -3.10 Mn
Sep 30, 2024 -3.10 Mn
Jun 30, 2024 -2.78 Mn
Jun 30, 2024 -2.78 Mn
Mar 31, 2024 -1.18 Mn
Mar 31, 2024 -1.18 Mn